1,298 material Form 8-K filings that 1,057 companies we cover made with the SEC in April 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Atlas Lithium said director Rodrigo Menck resigned effective immediately on April 1, 2026, citing personal reasons and no disagreement with the company. The board appointed Admiral (Ret.) Flávio Augusto Viana Rocha to fill the seat effective April 6, 2026, placing him on the Audit Committee.
Rodrigo Menck resigned from the board effective immediately, notified April 1, 2026; he served on no board committee
Admiral (Ret.) Flávio Augusto Viana Rocha, age 62, appointed director effective April 6, 2026
Rocha joins the Audit Committee and was determined by the board to be independent under Nasdaq rules
Rocha receives a cash fee of 50,000 Brazilian reais (about US$9,700) per month and no equity awards
Mattel said President and Chief Commercial Officer Steve Totzke will leave the role effective May 1, 2026, and serve as an executive advisor through December 31, 2026, when his employment ends. Sanjay Luthra, currently EMEA and Global Direct-to-Consumer managing director, will succeed him as Chief Commercial Officer and report to Chairman and CEO Ynon Kreiz. The filing describes a planned transition for a senior commercial leader, with severance and equity vesting tied to his departure.
Steve Totzke ceases to be President and Chief Commercial Officer effective May 1, 2026; employment ends December 31, 2026
Sanjay Luthra succeeds Totzke as Chief Commercial Officer, overseeing global sales and commercial operations
Totzke to receive severance, accelerated equity vesting, COBRA premium payments for up to eighteen months, and a car allowance for the same period
AppLovin announced leadership changes, including a new independent Chairperson, Craig Billings, effective April 2, 2026, succeeding Adam Foroughi, who remains CEO and a director. The CTO and Chief Legal Officer roles will pass to internal successors, and director Alyssa Harvey Dawson will not stand for re-election at the 2026 Annual Meeting. The filing contains no financial results, so the changes reflect governance and management succession rather than a change in reported performance.
Craig Billings becomes independent Chairperson, effective immediately, succeeding Adam Foroughi, who remains CEO and a Board member.
Giovanni Ge will become Chief Technology Officer when Basil Shikin steps down effective July 1, 2026; Shikin will become a Distinguished Engineer.
Victoria Valenzuela retires as Chief Administrative & Legal Officer effective August 1, 2026, will consult until May 31, 2027 for $150,000, and is nominated as a director; Corina Cacovean will become Chief Legal Officer.
Alyssa Harvey Dawson will not stand for re-election at the 2026 Annual Meeting; the filing says her decision was not due to any disagreement with the Company.
International Tower Hill Mines added Andrew Cole as a director effective April 1, 2026, to serve until the 2026 annual meeting. The filing describes him as a metals and mining veteran with more than 35 years of experience, including work on the Donlin Gold Project permits.
Andrew Cole appointed to the board effective April 1, 2026, serving until the 2026 annual general meeting of shareholders
Cole has not been named to any board committees at this time
Cole previously served as General Manager of the Donlin Gold Project in Alaska and held roles at Barrick Gold
Press release announcing the appointment was issued April 2, 2026
NRG Energy disclosed that director E. Spencer Abraham resigned from the Board effective April 3, 2026, citing personal reasons and saying the decision did not involve any disagreement with the company. The filing also states that he was not standing for re-election at the April 30, 2026 annual stockholder meeting, as part of the Board's ongoing succession planning.
E. Spencer Abraham resignation from the Board effective April 3, 2026; he informed the Board on April 2, 2026
Resignation attributed to personal reasons; filing states no disagreement with the company, management, or Board
Abraham was not standing for re-election at the annual stockholder meeting scheduled for April 30, 2026, per the March 18, 2026 proxy statement
Collegium Pharmaceutical's board approved Michael Donovan, a former Ernst & Young audit partner, as a director nominee for the 2026 annual meeting. Director John Fallon, M.D., who has served since 2016, said he will not stand for re-election and will retire from the board at that meeting, which the company says reflects board refreshment and succession planning rather than any disagreement.
Board approved Michael Donovan's nomination on April 6, 2026, for election at the 2026 Annual Meeting of Shareholders
Donovan, 60, was an EY audit partner from 2002 and Office Managing Partner of EY's Kendall Square biotechnology office from 2014 to 2024
Dr. John Fallon advised the board on April 2, 2026, that he will retire at the annual meeting after serving as a director since 2016
The company says Fallon's departure is not the result of any disagreement with the company
Azenta, Inc. said William 'Trey' E. Martin III became president of its Multiomics business effective April 6, 2026, replacing Ginger Zhou, who stepped down the same day and will advise the company through November 2026. Martin's offer letter sets a $540,000 base salary and a target bonus of 80% of base, with equity awards subject to Board approval. The company said the change is aimed at accelerating execution of the Multiomics long-range plan presented at its December 2025 Investor Day, and the filing also amends change-in-control severance terms for three executive officers.
Trey Martin became President, Multiomics, effective April 6, 2026, reporting to CEO John Marotta; he was CEO of Maravai LifeSciences from July 2023 to June 2025.
Ginger Zhou stepped down April 6, 2026, stating no disagreement with the company; she will advise through November 2026 under a consulting fee of $103,500.
Martin's offer letter: $540,000 base salary, 80% target bonus, target equity of about $1.7 million plus a one-time performance award of about $500,000, subject to Board approval.
Martin's non-change-in-control severance is 12 months of salary continuation, subject to a release of claims.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.